These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14171677)

  • 41. IMMUNIZATION WITH LIVE MEASLES VACCINE. REPORT OF A FIELD TRIAL IN HAWAII.
    ROTH A
    Hawaii Med J; 1965; 24():374-5. PubMed ID: 14327633
    [No Abstract]   [Full Text] [Related]  

  • 42. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin.
    Arbeter AM; Arthur JH; Blakeman GJ; McIntosh K
    J Pediatr; 1972 Oct; 81(4):737-41. PubMed ID: 4116365
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 44. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 45. MEASLES VACCINATION IN SOUTH AFRICA.
    GRASSET N; GEAR JH
    Arch Gesamte Virusforsch; 1965; 16():254-6. PubMed ID: 14322873
    [No Abstract]   [Full Text] [Related]  

  • 46. [ON THE PROBLEM OF THE RECURRENCE OF MEASLES IN CHILDREN].
    KAZANSKII IV; USPENSKAIA MD
    Pediatriia; 1963 Aug; 42():51-5. PubMed ID: 14089154
    [No Abstract]   [Full Text] [Related]  

  • 47. Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.
    STOKES J; HILLEMAN MR; WEIBEL RE; BUYNAK EB; HALENDA R
    N Engl J Med; 1962 Aug; 267():222-4. PubMed ID: 13917379
    [No Abstract]   [Full Text] [Related]  

  • 48. MEASLES VACCINATION IN ADULTS WITH AND WITHOUT COMPLICATING CONDITIONS.
    GUDNADOTTIR M; BLACK FL
    Arch Gesamte Virusforsch; 1965; 16():521-3. PubMed ID: 14322927
    [No Abstract]   [Full Text] [Related]  

  • 49. Administration of Enders' live measles virus vaccine with human immune globulin.
    WEIBEL R; HALENDA R; STOKES J; HILLEMAN MR; BUYNAK EB
    JAMA; 1962 Jun; 180():1086-94. PubMed ID: 14005592
    [No Abstract]   [Full Text] [Related]  

  • 50. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 52. Live, attenuated mumps-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
    [No Abstract]   [Full Text] [Related]  

  • 53. RESPONSE OF ADULTS IN ICELAND TO LIVE ATTENUATED MEASLES VACCINE.
    GUDNADOTTIR M; BLACK FL
    Bull World Health Organ; 1964; 30(6):753-62. PubMed ID: 14215182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attenuated measles-virus vaccine studies in Israel. I. Comparison of reactions after inoculation of vaccine with gamma-globulin.
    LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
    Am J Dis Child; 1962 Mar; 103():363-5. PubMed ID: 14464578
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 57. PROPHYLACTIC GAMMA GLOBULIN AND LIVE MEASLES VACCINE IN AN ISLAND OF MEASLES.
    BRODY JA; BRIDENBAUGH E
    Lancet; 1964 Oct; 2(7363):811-3. PubMed ID: 14187479
    [No Abstract]   [Full Text] [Related]  

  • 58. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. CLINICAL, IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY IN 50 INFANTS].
    MENEGHELLO J; UNDURRAGA O; ROSSELOT J; RODRIGUEZ M; HEVIA P
    Rev Chil Pediatr; 1963 Aug; 34():650-5. PubMed ID: 14089201
    [No Abstract]   [Full Text] [Related]  

  • 59. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
    BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
    J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
    [No Abstract]   [Full Text] [Related]  

  • 60. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.